We are live on
!
Find out more
AC
Argentiere Capital Portfolio holdings
AUM
$15.4M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
–
AUM
$15.4M
AUM Growth
-$215M
(-93%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-1,396.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
39
New
–
Increased
–
Reduced
1
Closed
37
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.55M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$5.54M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.42M |
| 4 |
AGN
Allergan plc
AGN
|
+$3.81M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 0% |
| 2 | Energy | 0% |
| 3 | Financials | 0% |
| 4 | Healthcare | 0% |
| 5 | Industrials | 0% |
No holdings matched the selected filter criteria.
Similar funds
TCM
HCA
DPA
MP
MMPI
AF
KAM
BA
Argentiere Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Argentiere Capital held 39 positions worth $15.4M, down 93% from $230M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Argentiere Capital withdrew a net $215M in Q2 2019, closing 37 positions and reducing 1 holding. Its most notable exit was Celgene Corp, an estimated $7.55M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 0% of assets, down from 2.4% a quarter earlier, followed by Energy and Financials.
- Argentiere Capital fully exited Celgene Corp in Q2 2019, selling an estimated $7.55M.
- Argentiere Capital's ten largest holdings make up 100% of its $15.4M portfolio in Q2 2019.
- Argentiere Capital opened 0 new positions and closed 37 in Q2 2019.
- Argentiere Capital's portfolio value fell 93% quarter-over-quarter to $15.4M.
Based on Argentiere Capital's 13F filing for Q2 2019, filed 14 Aug 2019.